Pharmaceuticals

Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe
Pfizer, BioNTech say vaccine expected to be ready for approval by December

If it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the end of 2021.

By REUTERS
10/07/2020
Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe
BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial

"These first trial results show that the vaccine yields immune activity and causes a strong immune response," said BioNTech's co-founder and Chief Executive Officer Ugur Sahin.

By REUTERS
01/07/2020
Bayer to test new drugs on 3D-printed heart tissue at Tel Aviv University

The new method of testing bypasses many tedious screening methods, making it faster, cheaper and more efficient.

29/06/2020
Canadian company Medicago develops plant-based coronavirus vaccine

The company has developed a unique method of creating a vaccine by letting plants do the work. "We're using plants as mini factories," said Natalie Charland, a senior director at Medicago.

Hillel's Tech Corner: CytoReason: Where AI meets drug development

CytoReason’s technology uses a machine learning model to build a molecular level understanding of tissues in diseases on the cellular level.

30/07/2020
The Lounge March 10, 2020: SuperPharm

A number of Super Pharm’s managers attended the ceremony, and Kupler and Keshet arranged to meet again in the future to discuss continued cooperation.

By MICHAL GALANTI
09/03/2020
Teva CEO Kåre Schultz at the Tel Aviv Stock Exchange, February 19, 2020
After turbulent years, Teva CEO Schultz forecasts stability

Teva completed its two-year major restructuring plan in 2019, reducing its cost base by over $3 billion and net debt by more than $9b.

19/02/2020
Professor Ruth Arnon, who was awarded the 2020 OurCrowd Maimonides Award for Lifetime Achievement in
86-year-old Copaxone creator has no intention of slowing down

When it comes to being excited by experiments, age is simply not a factor for 86-year-old Prof. Ruth Arnon, co-creator of multiple sclerosis drug Copaxone.

13/02/2020
Teva's first ever National Forum for Bio-Innovators gathers in Tel Aviv

Researcher Hila Flayev has for years been conducting research on computational models of the coronavirus structure and interactions it can create.

A sign stands at the edge of the campus of Tufts University in Medford, Massachusetts, U.S., Novembe
Tufts University to remove Sackler name from buildings and programs

Family has come under fire for their central role in American opioid crisis

08/12/2019
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use